Open AccessA MicroRNA Targeting Dicer for Metastasis Control
Author(s) -
Graziano Martello,
Antonio Rosato,
Francesco Ferrari,
Andrea Manfrin,
Michelangelo Cordesi,
Sirio Dupont,
Elena Enzo,
Vincenza Guzzardo,
Maria Rondina,
Thomas Spruce,
A. Parenti,
Maria Grazia Daidone,
Silvio Bicciato,
Stefano Piccolo
Publication year - 2010
Publication title -
cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 26.304
H-Index - 776
eISSN - 1097-4172
pISSN - 0092-8674
DOI - 10.1016/j.cell.2010.05.017
Subject(s) - dicer , biology , microrna , metastasis , downregulation and upregulation , cancer research , epithelial–mesenchymal transition , mesenchymal stem cell , cancer , cancer cell , microbiology and biotechnology , rna interference , genetics , rna , gene
Although specific microRNAs (miRNAs) can be upregulated in cancer, global miRNA downregulation is a common trait of human malignancies. The mechanisms of this phenomenon and the advantages it affords remain poorly understood. Here we identify a microRNA family, miR-103/107, that attenuates miRNA biosynthesis by targeting Dicer, a key component of the miRNA processing machinery. In human breast cancer, high levels of miR-103/107 are associated with metastasis and poor outcome. Functionally, miR-103/107 confer migratory capacities in vitro and empower metastatic dissemination of otherwise nonaggressive cells in vivo. Inhibition of miR-103/107 opposes migration and metastasis of malignant cells. At the cellular level, a key event fostered by miR-103/107 is induction of epithelial-to-mesenchymal transition (EMT), attained by downregulating miR-200 levels. These findings suggest a new pathway by which Dicer inhibition drifts epithelial cancer toward a less-differentiated, mesenchymal fate to foster metastasis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom